This inventor holds 6 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Stichting Voor De Technische Wetenschappen, Academisch Ziekenhuis Leiden (h.o.d.n. Lumc), Chiralix B.v.. Active years: 2011-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
5 out of 82 
1 out of 43 
1 out of 2 Years Active: 2011-2018
Title: The Innovations of Gerardus Jozef Maria Pruijn
Introduction
Gerardus Jozef Maria Pruijn is a notable inventor based in Beuningen, Netherlands. He has made significant contributions to the field of medical diagnostics, particularly in relation to rheumatoid arthritis. With a total of six patents to his name, Pruijn's work has had a meaningful impact on the detection of auto-antibodies in patients.
Latest Patents
Pruijn's latest patents include a method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, along with a peptide and assay kit. These peptides are useful in determining the presence of autoantibodies in patients suffering from this condition. His innovative approaches have paved the way for improved diagnostic techniques in the medical field.
Career Highlights
Throughout his career, Pruijn has worked with various organizations, including Stichting Voor De Technische Wetenschappen. His expertise in the field has allowed him to develop groundbreaking methods that enhance the understanding and diagnosis of autoimmune diseases.
Collaborations
Pruijn has collaborated with notable individuals such as Jan Wouter Drijfhout and Waltherus Jacobus Wilhelmus Van Venrooij. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Gerardus Jozef Maria Pruijn's contributions to medical diagnostics, particularly in the realm of rheumatoid arthritis, highlight his innovative spirit and dedication to improving patient care. His work continues to influence the field and offers hope for better diagnostic methods in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile